Group 1 - The company reported a 49% increase in revenue for Q2, reaching $61 million compared to $41.21 million a year earlier, exceeding analysts' expectations of $55.2 million [1][3] - The net loss for the quarter was $5.31 million, translating to a loss of 24 cents per share, an improvement from a net loss of $10.69 million or $1.40 loss per share in the same period last year [1][3] - CEO Sean Duffy highlighted the company's ability to capitalize on trends in cardiometabolic care and advancements in artificial intelligence as key factors in their performance [2]

Core Points - Teladoc Health Inc. will release its second quarter 2025 results on July 29, 2025, after market close [1] - A conference call to discuss the results will take place at 4:30 p.m. ET on the same day [1] - The company is recognized as a global leader in virtual care, aiming to transform healthcare experiences [4] Conference Call Details - U.S. participants can access the conference call by dialing 1-833-470-1428 with access code 606269 [2] - International participants can find global dial-in numbers through a provided link [2] - A live audio webcast will be available online for those who prefer to listen via the internet [2] Replay Information - A replay of the conference call will be available shortly after its completion for on-demand listening [3] - The replay will remain accessible for approximately 90 days [3] Company Overview - Teladoc Health empowers individuals to live healthier lives by enhancing the healthcare experience [4] - The company utilizes proprietary health signals and personalized interactions to improve health outcomes [4] - With over two decades of expertise, Teladoc Health addresses the increasing virtual care needs of consumers and healthcare professionals [4]